文献速递儿童青少年精神

ASD活体生物学:从细胞增殖到临床表型

The ASD Living Biology: from cell proliferation to clinical phenotype.
PubMed 文献 · Mol Psychiatry · 2018-06-22

本文综述遗传、基因组、细胞、尸检、动物模型和细胞模型证据,提出ASD是始于子宫内的多阶段进展性脑发育障碍,涉及细胞增殖分化、神经迁移、突触形成等过程 disrupted。94%的高置信度ASD基因在产前表达并影响这些胎儿过程。作者提出「ASD活体生物学」概念,倡导整合产前体外与产后体内信息以实现个体化解释和精准医学。

要点

  • ASD是始于产前的多阶段进展性脑发育障碍,涉及增殖、迁移、突触形成等过程。
  • 94%的高置信度ASD基因在产前表达,影响新皮层、杏仁核、海马、纹状体和小脑的胎儿过程。
  • 提出「ASD活体生物学」概念,倡导整合产前体外与产后体内信息实现个体化精准医学。

核心结论

  • ASD的发病机制并非设定于某一时间点或单一过程,而是绝大多数ASD幼儿产前致病过程的级联反应。
  • 当前研究方法尚未提供个体化信息,缺乏对每个ASD儿童胎儿过程和早期分子细胞差异的了解,阻碍了基于生物学的诊断、预后和精准医学治疗的快速进展。

研究设计与样本

  • 本文为综述,汇总了遗传、基因组、细胞、尸检、动物模型和细胞模型证据。
  • 文中还回顾了首个将产前体外分子、细胞和神经测量与产后体内分子、神经和临床表现及进展相联系的研究。

主要发现

  • ASD可早在妊娠第一和第二 trimester 开始,表现为细胞增殖和分化 disrupted,并持续涉及神经迁移 disrupted、层状结构紊乱、神经元成熟和神经突生长改变、突触形成 disrupted 和神经网络功能降低。
  • 94%的最常报告的高置信度ASD(hcASD)基因在产前表达,并影响新皮层、杏仁核、海马、纹状体和小脑中的这些胎儿过程。
  • 大多数hcASD基因是多效性的,影响增殖/分化和/或突触发育。
  • 妊娠第一 trimester 的母体免疫激活也可 disrupted 增殖和随后的胎儿阶段。
  • 常见涉及的PI3K/AKT和RAS/ERK通路也是多效性的,影响从增殖到突触和神经功能发育的多个胎儿过程。

关键数值与推荐

  • 在不同ASD个体中,这些多效性通路失调的方式和时间变异将导致不同甚至相反的效果,产生产前以及 later 神经和临床异质性。

临床怎么用

  • ASD活体生物学范式通过将每个ASD儿童的遗传和体外产前分子、细胞和神经测量与产后体内分子、神经和临床表现及进展相联系来寻求知识。
  • 该范式倡导整合产前体外和产后早期体内信息,以生成个体化和群体水平的解释、临床有用的预后和真正有益于ASD婴幼儿个体的精准医学方法。

局限性

  • 当前研究方法尚未提供个体化信息:每个ASD儿童背后的胎儿过程和早期分子细胞差异是什么。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autism spectrum disorder (ASD) has captured the attention of scientists, clinicians and the lay public because of its uncertain origins and striking and unexplained clinical heterogeneity. Here we review genetic, genomic, cellular, postmortem, animal model, and cell model evidence that shows ASD begins in the womb. This evidence leads to a new theory that ASD is a multistage, progressive disorder of brain development, spanning nearly all of prenatal life. ASD can begin as early as the 1st and 2nd trimester with disruption of cell proliferation and differentiation. It continues with disruption of neural migration, laminar disorganization, altered neuron maturation and neurite outgrowth, disruption of synaptogenesis and reduced neural network functioning. Among the most commonly reported high-confidence ASD (hcASD) genes, 94% express during prenatal life and affect these fetal processes in neocortex, amygdala, hippocampus, striatum and cerebellum. A majority of hcASD genes are pleiotropic, and affect proliferation/differentiation and/or synapse development. Proliferation and subsequent fetal stages can also be disrupted by maternal immune activation in the 1st trimester. Commonly implicated pathways, PI3K/AKT and RAS/ERK, are also pleiotropic and affect multiple fetal processes from proliferation through synapse and neural functional development. In different ASD individuals, variation in how and when these pleiotropic pathways are dysregulated, will lead to different, even opposing effects, producing prenatal as well as later neural and clinical heterogeneity. Thus, the pathogenesis of ASD is not set at one point in time and does not reside in one process, but rather is a cascade of prenatal pathogenic processes in the vast majority of ASD toddlers. Despite this new knowledge and theory that ASD biology begins in the womb, current research methods have not provided individualized information: What are the fetal processes and early-age molecular and cellular differences that underlie ASD in each individual child? Without such individualized knowledge, rapid advances in biological-based diagnostic, prognostic, and precision medicine treatments cannot occur. Missing, therefore, is what we call ASD Living Biology. This is a conceptual and paradigm shift towards a focus on the abnormal prenatal processes underlying ASD within each living individual. The concept emphasizes the specific need for foundational knowledge of a living child's development from abnormal prenatal beginnings to early clinical stages. The ASD Living Biology paradigm seeks this knowledge by linking genetic and in vitro prenatal molecular, cellular and neural measurements with in vivo post-natal molecular, neural and clinical presentation and progression in each ASD child. We review the first such study, which confirms the multistage fetal nature of ASD and provides the first in vitro fetal-stage explanation for in vivo early brain overgrowth. Within-child ASD Living Biology is a novel research concept we coin here that advocates the integration of in vitro prenatal and in vivo early post-natal information to generate individualized and group-level explanations, clinically useful prognoses, and precision medicine approaches that are truly beneficial for the individual infant and toddler with ASD.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Courchesne E, Pramparo T, Gazestani VH, et al. The ASD Living Biology: from cell proliferation to clinical phenotype. Mol Psychiatry. 2018. PMID: 29934544. doi:10.1038/s41380-018-0056-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。